In this study, the refined assay was used to evaluate the clinical significance of CDX2 pCTCs in CRC by detecting such cells in patients with CRC, colorectal adenoma (CAD), benign colorectal diseases (BCD) and other common cancers (OCC). Here, CDX2 is linked to colorectal adenoma.